July 11, 2017
On May 25, 2017, Gov. Hogan signed SB 919 into law. The new law prohibits insurers that provide coverage for prescription drugs from imposing a step therapy or fail-first protocol on a participant when the prescribed drug is approved by the U.S. Food and Drug Administration and the drug is used to treat the participant’s stage four advanced metastatic cancer. Step therapy or fail-first protocol refers to a protocol administered by the insurer that requires a prescription drug or sequence of drugs to be used by the participant before a drug ordered by the participant’s prescribing health care provider can be issued or used. The law is effective for policies issued or renewed on or after Oct. 1, 2017.
SB 919 »